巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Repligen Corp

RGEN
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Repligen Corp - 延遲價格・最後更新於 28/01 12:14
最高位
189.990
最低位
176.900
開市價
--
前收市價
177.280
成交量(千)
14.30
成交額(百萬)
22.42
買入
--
賣出
--
每手股數
--
市值(百萬)
10,492.10
市盈率
90.370
息率
--
差價
--
52週高低
327.320 - 162.290
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Repligen Corp
證券代碼
RGEN.US
所屬板塊
Medical Instruments & Supplies
公司業務
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.
發行量
54899242
公司總部
41 Seyon Street, Building 1, Suite 100
公司網址
https://www.repligen.com
公司電郵
investors@repligen.com
公司電話
+1 781 250-0111
暫無內容

關於

Repligen Corp(RGEN.US)所屬的行業板塊為Medical Instruments & Supplies。
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.
詳細公司背景可參考: https://www.repligen.com